This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Oct;55(4):599-600.

doi: 10.1002/pbc.22652.

Continuously improving ifosfamide/mesna: a winning combination

Peter Anderson¹

Affiliations

PMID: 20589648
DOI: 10.1002/pbc.22652

Comment

Continuously improving ifosfamide/mesna: a winning combination

Peter Anderson. Pediatr Blood Cancer. 2010 Oct.

. 2010 Oct;55(4):599-600.

doi: 10.1002/pbc.22652.

Author

Peter Anderson¹

Affiliation

¹ Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. pmanders@mdanderson.org

PMID: 20589648
DOI: 10.1002/pbc.22652

No abstract available

PubMed Disclaimer

Comment on

Prolonged 14-day continuous infusion of high-dose ifosfamide with an external portable pump: feasibility and efficacy in refractory pediatric sarcoma.
Meazza C, Casanova M, Luksch R, Podda M, Favini F, Cefalo G, Massimino M, Ferrari A. Meazza C, et al. Pediatr Blood Cancer. 2010 Oct;55(4):617-20. doi: 10.1002/pbc.22596. Pediatr Blood Cancer. 2010. PMID: 20589638

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information